COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease

dc.contributor.author	Kronenberger, Thales
dc.contributor.author	Pillaiyar, Thanigaimalai
dc.contributor.author	Laufer, Stefan
dc.date.accessioned	2023-09-08T07:54:39Z
dc.date.available	2023-09-08T07:54:39Z
dc.date.issued	2023
dc.identifier.issn	1359-6446
dc.identifier.uri	http://hdl.handle.net/10900/145346
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.drudis.2023.103579	de_DE
dc.subject.ddc	610	de_DE
dc.title	COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230619000000_00401
utue.personen.roh	Kronenberger, Thales
utue.personen.roh	Laufer, Stefan A.
utue.personen.roh	Pillaiyar, Thanigaimalai
dcterms.isPartOf.ZSTitelID	Drug Discovery Today	de_DE
dcterms.isPartOf.ZS-Issue	6	de_DE
dcterms.isPartOf.ZS-Volume	28	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE
utue.fakultaet	08 Zentrale, interfakultäre und fakultätsübergreifende Einrichtungen	de_DE